MedTrace Logo

Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.

NCT04380584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-05-11

No results posted yet for this study

Summary

Diabetic nephropathy (DN) is the commonest cause of chronic kidney disease, and proteinuria isn't determent factor for the end stage renal disease in diabetics. Apelin is adipokine and have a beneficial role in early prediction of diabetic nephropathy. Few studies were done about apelin in diabetes. Purpose of the study: to investigate the association between the apelinergic system and diabetic nephropathy.

Conditions

  • Diabetic Nephropathies

Interventions

DIAGNOSTIC_TEST

plasma Apelin level

blood sample for detection of plasma Apelin level

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2020-03-20
Completion
2020-03-29

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04380584 on ClinicalTrials.gov